Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 2005, p. 3414-3420, Vol. 43, No. 7
0095-1137/05/$08.00+0 doi:10.1128/JCM.43.7.3414-3420.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington 99164-7040,1 The Zoological Society of San Diego, Center for Reproduction of Endangered Species, P.O. Box 120551, San Diego, California 92112-0551,2 The Peregrine Fund, 5668 West Flying Hawk Lane, Boise, Idaho 837093
Received 9 August 2004/ Returned for modification 7 November 2004/ Accepted 5 December 2004
|
|
|---|
|
|
|---|
Epidemiologic investigation (12) indicated that the outbreak began with infection of a single neonatal aplomado falcon, with subsequent horizontal spread among the rest of the aplomado falcon chicks in the brooder room. However, the source of the initial infection was not known. The eggs from which these falcons hatched were naturally incubated for about 1 week by either peregrine or aplomado falcons, followed by artificial incubation. After hatching, the neonates were all hand raised and thus had no direct contact with any adult falcons. In the few previous reports of adenovirus infections of falcons (4, 10, 14), the source of infection was not determined. Forbes et al. (4) hypothesized that the agent was a poultry virus and that exposure of falcons occurred through food sources. This was based on isolation of an adenovirus from the chickens and turkeys used to feed the falcons. However, the ubiquitous nature of adenoviruses and the lack of any direct comparison of the falcon and fowl isolates made the association circumstantial (4).
Molecular characterization has identified the falcon virus as a new member of the aviadenovirus group (12); this new member is most closely related to the group I avian adenoviruses. The original working hypothesis concerning the outbreak was that the virus was introduced to the brooder room via the food quail. However, evidence that this adenovirus was distinct from the known poultry adenoviruses challenged the hypothesis that it originated from the food source. The purpose of this study was to isolate and propagate the falcon adenovirus and to use the virus for challenge studies and as an antigen in serologic assays to define the host range and natural history of the falcon adenovirus. This information would also be useful in determining the source of the virus in the original outbreak and in designing strategies to prevent future outbreaks.
|
|
|---|
Tissue pools of approximately 1 g of liver and 0.5 g of spleen from affected aplomado falcons were first homogenized with Dounce tissue grinders in 10 ml of MEM supplemented with 200 U ml1 penicillin and 0.2 mg ml1 streptomycin and then briefly centrifuged at 750 x g to remove tissue and cellular debris; then 500 µl of the sample was inoculated onto confluent monolayers of cells in 25-cm2 flasks. The sample was incubated with the cells for 1 h at 37°C, after which time an additional 5 ml of supplemented medium was added to the flasks. The cell cultures were incubated under 5% CO2 at 37°C for 7 to 14 days and observed for cytopathology. Cell cultures were passaged by freezing and thawing the flasks, collecting the cells and supernatants, and adding 1 ml of this lysate to new cells in 25-cm2 flasks.
Electron microscopy. Portions (1.5) ml of cell supernatants were collected from cell cultures with visible cytopathology, centrifuged at 1,000 x g for 10 min to pellet large cellular debris, and centrifuged at 8,000 x g for 10 min to further remove debris; then 1 ml of the clarified supernatant was centrifuged at 13,000 x g for 30 min to pellet virions. The virus pellet was resuspended in 50 µl of distilled water, negatively stained with 1% phosphotungstic acid for 30 s, mounted onto 200-mesh Formvar-coated copper grids, and viewed by transmission electron microscopy.
PCR assay and sequencing. Falcon adenovirus was detected in cell cultures or tissues by using a PCR assay specific for the falcon adenovirus hexon gene as described by Schrenzel et al. (12). DNA was extracted and purified from infected cell monolayers or tissue samples by standard phenol-chloroform and ethanol precipitation methods, and 1 µg of total DNA was used in each PCR. The identity of the amplified DNA as falcon adenovirus was confirmed by cloning the amplicon into the pCR2.1 sequencing vector (TOPO TA cloning kit; Invitrogen, Carlsbad, CA), and sequencing by automated dideoxy DNA methods.
Serology. The serum neutralization (SN) assay was modified from a previously published microneutralization procedure (5). Serum or plasma was collected from various species of raptors and other birds, stored at 20°C, and heat inactivated at 56°C for 30 min prior to use. Stocks of the falcon adenovirus were prepared by propagating the virus in peregrine embryo fibroblasts in 25-cm2 flasks until maximal cytopathology was evident. At this time, the cell monolayers were harvested by mechanically scraping free the cell monolayers, releasing intracellular virions by two freeze-thaw cycles, centrifuging to pellet cellular debris, and making 1-ml aliquots of the virus, which were stored at 80°C until use. The titer of the virus stock was determined by performing eight replicate 10-fold serial dilutions on peregrine embryo fibroblasts and scoring the well as positive or negative for cytopathology. The titer as the median tissue culture infective dose (TCID50) was then calculated by the method of Reed and Muench (9). Stocks of fowl adenovirus type 1 (chicken embryo lethal orphan [CELO] strain) were similarly prepared and titered.
To perform the SN assay, 100 TCID50s of virus stock were mixed with test sera/plasma and cell culture media to give final serum dilutions of 1:5, 1:10, or 1:40 in a total volume of 100 µl. For selected cases, twofold serial dilutions of the sera/plasma were made (range, 1:10 to 1:5,120) to detect the end point titers. The serum-virus mixture was incubated at 37°C for 1 h, and then the entire 100 µl was added to newly confluent peregrine embryo fibroblasts in 96-well plates. The plates were then incubated at 37°C under a 5% CO2 atmosphere for 10 to 14 days, after which time the wells were scored as positive or negative for cytopathology. The titer was reported as the reciprocal of the highest dilution that completely inhibited cytopathology.
Experimental infections of live quail. All experiments using live birds were approved by the Washington State University Institutional Animal Care and Use Committee. To attempt to reproduce disease and determine the host range for the virus, Japanese quail were infected with tissue pools from infected aplomado falcons. These tissue pools were shown to have infectious virus by isolation in cell culture. The source flock for the quail was negative for adenovirus titers by agar gel precipitation assays against group I and group II aviadenoviruses (performed commercially by the Poultry Diagnostic and Research Center at the University of Georgia). Two groups of three 2-day-old quail each were inoculated either orally with 10 µl or by intramuscular injection with 10 µl of liver/spleen tissue homogenates from aplomado falcons RP5958 and 96JT1,6. One quail in each group was also left uninoculated as a contact control. At 19 days postinoculation, all of the quail in both groups, including the contact controls, were reinoculated by intramuscular injection with 100 µl of tissue homogenates from the respective falcons. Another two groups of two 8-week-old quail each were inoculated using 100 µl for the initial oral and intramuscular administrations and 200 µl for the subsequent intramuscular reinoculation. Groups of four age-matched control quail were housed in the same room but in separate cages. The birds were observed daily for any clinical evidence of disease. At day 29 postinoculation, all the birds were euthanized for collection of serum and tissues. SN assays for antibodies to fowl adenovirus type 1 in experimentally infected quail were performed commercially by the Poultry Diagnostic and Research Center, University of Georgia.
|
|
|---|
![]() View larger version (186K): [in a new window] |
FIG. 1. Electron micrograph of virus particle identified in quail embryo fibroblast cell culture of aplomado falcon RP5958. Virions have the characteristic icosahedral shape of adenoviruses. Magnification, x60,000.
|
The cell culture supernatant from the third passage of duck liver fibroblasts for case 96JT1,6, which was positive by PCR and electron microscopy, was used to inoculate peregrine falcon embryo fibroblasts. In the peregrine cells, cytopathology characterized by rounded, refractile cells was detectable by day 4 to 5 postinfection and then progressed over the next 5 days to extensive cytopathology with many pyknotic cells (Fig. 2). Five subsequent passages onto fresh peregrine falcon fibroblasts resulted in extensive and reproducible cytopathology in all passages by about day 10 postinfection and titers of approximately 2 x 103 to 3 x 103 TCID50s ml1. These passages were also all PCR positive. Comparison of the sequences of the PCR amplicons from falcon tissues and cell cultures confirmed that the cultured adenovirus was the falcon adenovirus.
![]() View larger version (75K): [in a new window] |
FIG. 2. (A) Cytopathic effect of the falcon adenovirus in peregrine falcon embryo fibroblasts. (B) Uninfected control cells. Bars, 20 µm.
|
40. End point titers were determined for five of the adult peregrines; they ranged from 640 to 1,280. Attempts to determine the end point titers for five of the surviving neonatal aplomado falcons showed that all birds had very high titers of
5,120. These results are summarized in Table 1. |
View this table: [in a new window] |
TABLE 1. Reciprocal serum neutralization titers against the falcon adenovirus in raptors and other birds at the breeding facility, 1995 to 2002a
|
40, indicating that the virus was present at the facility at least 1.5 years prior to the outbreak. Seven adult aplomado falcons and five adult peregrine falcons were tested in 1999, 3 years after the outbreak. Four of the aplomado falcons were positive with titers of 10 to
40, and three were seronegative at a dilution of 1:10. All five of the peregrine falcons were strongly seropositive, with titers of
40. These data indicated either that the titers were persistent or that exposure was ongoing, especially in the peregrine falcons. These results are summarized in Table 1.
Subsequently, other raptors and species of birds at the breeding facility were also tested for SN antibody titers (Table 1). This included seven adult gyrfalcons tested in 2002, of which three (43%) had titers of 10 to
40 and four were seronegative at a dilution of 1:10. All other birds tested were seronegative at titers of 1:10, including 5 harpy eagles in 1999, 4 pigeons in 2001, 2 chukar partridges in 2001, 4 of the food quail in 2001, and 10 of the food chickens in 2002. These initial results indicated that infection with the falcon adenovirus was limited to birds in the genus Falco, and the high and persistent titers in the adult peregrine falcons suggested that infection was endemic in this species. An additional five chickens from mixed flocks not associated with the breeding facility were also tested and found seronegative at dilutions of 1:10 (Table 2).
|
View this table: [in a new window] |
TABLE 2. Reciprocal serum neutralization titers against the falcon adenovirus in raptors and chickens not from the breeding facilitya
|
40, eight (27%) had titers of 10, and only six (20%) were seronegative. The end point titer of one of the seropositive wild peregrines was determined to be
640.
Cross-neutralization SN assays indicated serologic cross-reactivity between the falcon adenovirus and its closest genetic relative, fowl adenovirus type 1 (12). The five neonatal aplomado falcons and the five adult peregrine falcons with very high SN titers to the falcon adenovirus had SN activity against fowl adenovirus type 1. However, the titers to the falcon adenovirus ranged from 640 to
5,120 (median titer, >3,200), while the titers to fowl adenovirus type 1 ranged from 40 to 320 (median titer, 80). Thus, the type-specific SN titer for the falcon adenovirus was >40-fold higher than that for fowl adenovirus type 1. Quail with SN titers of 2 to 16 against fowl adenovirus type 1 did not have SN titers to the falcon adenovirus at dilutions of 1:5.
Experimental infections of live quail. None of the experimentally infected quail showed any evidence of clinical disease at any time during the experiment. At necropsy, no gross or microscopic lesions suggestive of adenovirus infection were identified. Seroconversion to the falcon adenovirus was not detected in any of the quail by SN with screening dilutions of 1:5 (Table 3), suggesting that the quail were resistant to infection as well as to clinical disease. Although the quail were seronegative for fowl adenovirus type 1 (group I) by agar gel precipitation assays, some quail had titers ranging from 4 to 32 by the more sensitive SN assay (Table 3). However, the lack of falcon adenovirus titers in the exposed quail, and the positive titers to fowl adenovirus type 1 in the control quail, indicated that these titers were most likely preexisting and not related to the falcon adenovirus.
|
View this table: [in a new window] |
TABLE 3. Experimental infections of Japanese quail with liver/spleen tissues from aplomado falcons RP5958 and 96JT1,6a
|
|
|
|---|
The data from this study also implicate the peregrine falcon as a primary reservoir host for the falcon adenovirus. The very high and persistent 100% seroprevalence in the captive peregrine falcons suggests a very high infection rate and endemicity, respectively. The high seroprevalence may in part be explained by the close physical proximity of the birds at a single facility. However, adult aplomado falcons and adult gyrfalcons kept on the same premises had much lower seroprevalence rates (57% and 43%, respectively), suggesting that they are not as susceptible to infection. The 80% SN seroprevalence in wild peregrine falcons, and the lower seroprevalence in other falcon species outside of the breeding facility, suggests that this virus is naturally endemic in peregrine falcons, although infection with this or a closely related virus does occur in other wild falcon species (e.g., American kestrels). The other finding suggesting that peregrine falcons are the natural host for the virus is their apparent resistance to clinical disease. In the aplomado falcon outbreak in which the attack rate for aplomado falcons was 65%, the attack rate for peregrine falcons living in close proximity was only 6%. One possible explanation for the resistance of the neonatal peregrines to disease is the SN titers in the parent birds and passive protection by antibody. However, the deaths of six neonatal peregrines and the deaths of aplomado falcons hatched from females shown to have preexisting SN titers (MEMI, TWA, and LO) indicate that passive antibody either is not protective or requires high titers for protection. These data also caution that intervention strategies such as vaccination of adults may not be adequate for prevention of outbreaks in susceptible populations.
There also appears to be considerable variation in susceptibility to clinical disease among the other species of falcons. Of particular interest are deaths of adult falcons, which suggest that these species are highly susceptible to infection and disease. Lethal adenovirus infections have been described among adult Mauritius kestrels (4), Fijian peregrine falcons (12), orange-breasted falcons (12), American kestrels (14), and a merlin (Falco columbarius) (10). Interestingly, adult mortality appears to be most common in falcon species of island/tropical origin and/or in the smaller falcon species such as kestrels and merlins. The reason for the increased susceptibility of these species in not known, but it can be speculated to be due either to genetic susceptibility or to a lack of natural exposure and immunity, or both. Although the sample sizes were small, the lack of SN titers in a group of captive adult teita falcons and a group of captive orange-breasted falcons suggests that the virus is not endemic in these species. Thus, captive populations of these species should be considered at especially high risk for falcon adenovirus disease. Deaths have been recorded for two neonatal teita falcons (A. Wunschmann, personal communication) produced from the above group of adults when the neonates were moved to a new facility with gyrfalcons and peregrine falcons. Although adult gyrfalcons may be seropositive, adenovirus deaths among neonates or adults have not been recorded, and thus, this species appears to be relatively resistant to clinical disease. Deaths were recorded for two neonatal gyrfalcon-peregrine hybrids that were housed with, and died subsequently to, the teita falcons (A. Wunschmann, personal communication). In this case, as for the peregrine falcons, inherent resistance to disease may be overcome in neonates with overwhelming challenge doses. Despite the high mortality rate among neonatal aplomado falcons during the 1996 outbreak, the ability of adult aplomado falcons to seroconvert without clinical disease and the apparent ability of neonates to survive certain levels of exposure (mortality decreased after implementation of biosecurity measures which presumably decreased the challenge doses, although serology showed that the falcons were still infected) suggest that aplomado falcons are also relatively resistant to disease.
Based on the information from this study, the primary control measure for falcon adenovirus disease should be based on segregation of and biosecurity between the carrier falcons and known or suspected susceptible species. In particular, until more information is available regarding the epidemiology and pathophysiology of this virus, great care should be taken if peregrine falcons are housed with other species of falcons.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»